Showing 231-240 of 18069 results for "".
Parents Live into Their 90's at Lower Risk for Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/parents-live-into-their-90s-at-lower-risk-for-type-2-diabetes/13672/This research shows that patients whose parents live into their 90s are at lower risk for type 2 diabetes—and so are their spouses.Neonatal Diabetes: A Special Case of Type 1 Diabetes
https://reachmd.com/programs/clinicians-roundtable/neonatal-diabetes-a-special-case-of-type-1-diabetes/1690/Dr. Louis Philipson from the University of Chicago joins host Dr. Danny Petrasek to discuss Neonatal Diabetes and the clinical trials behind discovering treatments for this disease.Clinical Trials to Cure Type 1 Diabetes With Generic Drugs
https://reachmd.com/programs/focus-on-diabetes/clinical-trials-to-cure-type-1-diabetes-with-generic-drugs/3853/The first clinical trial using generic drugs to cure type 1 diabetes has created quite a buzz in the diabetic patient and physician communities. Join host Dr.Bruce Bloom and his guest, Dr. Denise L. Faustman, associate professor of medicine at Harvard Medical School and director of the ImmunobiologyBehind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell Therapies
https://reachmd.com/programs/cme/behind-the-screens-innovations-in-type-1-diabetes-clinical-trialsfrom-immunomodulation-to-screening-strategies-and-advanced-cell-therapies/39701/Behind the Screens: Innovations in Type 1 Diabetes Clinical Trials—From Immunomodulation to Screening Strategies and Advanced Cell TherapiesUpdated Target Blood Sugar Levels for Type 2 Diabetes Patients
https://reachmd.com/programs/what-your-patients-are-talking-about/updated-target-blood-sugar-levels-type-2-diabetes-patients/7387/According to a report in the New England Journal of Medicine, doctors now have updated targets for lowering blood sugar in their Type 2 diabetes patients.Prova Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 3
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-3/6566/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems oProva Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 2
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-2/6565/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems oProva Education -- Improving Treatment for Type 2 Diabetes: Overcoming Barriers to Optimal Care, Part 1
https://reachmd.com/programs/grand-rounds-nation/prova-education-improving-treatment-for-type-2-diabetes-overcoming-barriers-to-optimal-care-part-1/6564/This program will address the increasing prevalence of overweight, obese and type 2 diabetes conditions in our patient population. Physicians and healthcare professionals are confronted with multiple treatment and management challenges for type 2 diabetes. Treatment goals and care-delivery systems oUpdates in the Classification & Diagnosis of Type 2 Diabetes
https://reachmd.com/programs/diabetes-discourse/updates-in-the-classification-diagnosis-of-type-2-diabetes/6641/Host Dr. Farhad Zangeneh welcomes Dr. Kathleen "Kittie" Wyne from the The Methodist Hospital Research Institute (TMHRI) in Houston where she also coordinates their clinical research program in The Diabetes Research Center. Dr. Wyne discusses the changing classification of diabetes and pre-diabetes aNovel Treatments for Diabetes
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/novel-treatments-for-diabetes/1787/Dr. Lazar discusses exciting new innovations in our approach to both type I and type II diabetes including Islet cell transplantation, medications for beta cell preservation and new insights into the control of obesity.